Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IIPR
IIPR logo

IIPR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Innovative Industrial Properties Inc (IIPR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
50.160
1 Day change
-1.18%
52 Week Range
59.830
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Innovative Industrial Properties Inc (IIPR) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock's technical indicators, financial performance, and lack of positive catalysts suggest a cautious approach. While there are no immediate sell signals, the current setup does not present a compelling entry point.

Technical Analysis

The MACD is negatively expanding (-0.311), indicating bearish momentum. RSI is neutral at 41.498, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 52.629, with immediate support at 51.522 and resistance at 53.737. Overall, technical indicators suggest a lack of strong upward momentum.

Options Data

Bearish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high Put-Call Ratios indicate bearish sentiment in both open interest and daily trading volume, suggesting traders are positioning for potential downside.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
4

Positive Catalysts

  • NULL identified. There is no recent news or significant positive developments in the stock or its industry.

Neutral/Negative Catalysts

  • Declining financial performance in Q4 2025, with revenue down 13.14% YoY, net income down 22.95% YoY, and EPS down 22.63% YoY. The cannabis and life sciences industries face uncertainty, with tenant credit issues still unresolved.

Financial Performance

In Q4 2025, the company reported a revenue decline to $66.657 million (-13.14% YoY), net income dropped to $29.964 million (-22.95% YoY), and EPS fell to 1.06 (-22.63% YoY). Gross margin also declined to 60.22% (-9.09% YoY), indicating worsening profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst ratings are neutral to negative. Compass Point upgraded the stock to Neutral from Sell with a $45 price target. Alliance Global raised the price target to $55 from $50, maintaining a Neutral rating. Piper Sandler raised the price target to $45 from $44 but kept an Underweight rating, citing ongoing tenant credit issues and industry uncertainty.

Wall Street analysts forecast IIPR stock price to rise
4 Analyst Rating
Wall Street analysts forecast IIPR stock price to rise
1 Buy
2 Hold
1 Sell
Hold
Current: 50.760
sliders
Low
44
Averages
61.33
High
90
Current: 50.760
sliders
Low
44
Averages
61.33
High
90
Compass Point
Merrill Ross
Sell
to
Neutral
upgrade
$45
AI Analysis
2026-03-03
Reason
Compass Point
Merrill Ross
Price Target
$45
AI Analysis
2026-03-03
upgrade
Sell
to
Neutral
Reason
Compass Point analyst Merrill Ross upgraded Innovative Industrial Properties to Neutral from Sell with an unchanged price target of $45.
Alliance Global
Aaron Grey
Neutral
maintain
$50 -> $55
2026-02-26
Reason
Alliance Global
Aaron Grey
Price Target
$50 -> $55
2026-02-26
maintain
Neutral
Reason
Alliance Global analyst Aaron Grey raised the firm's price target on Innovative Industrial Properties to $55 from $50 and keeps a Neutral rating on the shares. The firm cites improved visibility into the company's return to rent on defaulted assets for target boost post the Q4 report.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for IIPR
Unlock Now

People Also Watch